Clinical Trials Browser

Liver Diseases, Liver Neoplasms, Liver Failure

NCT07053488 2025-07-08

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Phase 1/2 Recruiting

90 enrolled

Gastrointestinal

Fatty Liver, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT05484908 2024-11-29

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Phase NA Recruiting

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Failure

NCT04574050 2024-03-19

SELF-BREATHE RCT for Chronic Breathlessness

Phase NA Completed

52 enrolled

Classical hematologyOther

Anemia, Sickle Cell, Asthma, Cystic Fibrosis, Dyspnea, Neoplasms, Liver Failure, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

NCT01429038 2022-06-14

Mesenchymal Stem Cells After Renal or Liver Transplantation

Phase 1/2 Completed

40 enrolled

Genitourinary

Fibrosis, Kidney Diseases, Liver Diseases, Neoplasms, Liver Failure, Liver Failure, Acute, Renal Insufficiency

NCT04351880 2022-02-17

Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

Phase NA Completed

650 enrolled

Genitourinary

Chronic Disease, Diabetes Mellitus, Heart Failure, Kidney Failure, Chronic, Neoplasms, Liver Failure, Pulmonary Disease, Chronic Obstructive

NCT03908255 2022-01-28

BCAA in HCC

Phase 2 Withdrawn

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

NCT04107324 2021-01-15

ARAPS

Phase NA Unknown

30 enrolled

Gastrointestinal

Liver Neoplasms, Liver Failure

NCT02635347 2019-08-20

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Phase NA Completed

31 enrolled 22 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Failure

NCT01643447 2016-03-31

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Phase NA Completed

200 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Failure

NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Phase 2 Completed

140 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

NCT01423708 2012-07-18

EPOCAL

Phase 2 Unknown

117 enrolled

Gastrointestinal

Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT00325611 2006-05-15

Multidisciplinary Inpatient Palliative Care Intervention

Phase NA Completed

550 enrolled

Genitourinary

Acquired Immunodeficiency Syndrome, Coronary Artery Disease, Dementia, Diabetes Mellitus, Failure to Thrive, Heart Failure, Kidney Failure, Chronic, Neoplasms, Pneumonia, Respiratory Insufficiency, Liver Failure, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

Clinical Trials

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

SELF-BREATHE RCT for Chronic Breathlessness

Mesenchymal Stem Cells After Renal or Liver Transplantation

Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

BCAA in HCC

ARAPS

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Use of N-Acetylcysteine During Liver Procurement

EPOCAL

Multidisciplinary Inpatient Palliative Care Intervention